Sparsentan
Systematic Name
2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide
Therapeutic Category
Renal disease agent
CAS No
254740-64-2
Suitable Formulations
Solid
Approvals
Under Development